Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00297232
Status:
TERMINATED
Last Update Posted:
2016-07-15
First Post:
2006-02-27
Brief Title:
Natalizumab Tysabri Re-Initiation of Dosing
Sponsor:
Biogen
Organization:
Biogen